BioSpace News Archive

As per Future Market Insights, driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth at 4.90% CAGR in 2021.

Valneva SE, a specialty vaccine company, announced the successful completion of the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553.

SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is opening a 175 square meter state-of-the-art BSL2/GMO2-classified laboratory in Copenhagen.

Electromedical Technologies, Inc. is excited to announce that the Company has hired its first Business and Sales Development Director, David Orn, to drive a material expansion of sales and strategic distribution channels for Electromedical’s flagship Wellness Pro Plus next-generation therapeutic device.

United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Oppenheimer 32nd Annual Healthcare Conference.

Alzheon, Inc. announced that it will be presenting at the 16th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders to be held on March 15-20, 2022, in Barcelona, Spain, and the 10th Annual Neurodegenerative Drug Development Summit to be held on March 28-30, 2022, in Boston, MA, USA.

Voyager Therapeutics, Inc., a gene therapy company developing life-changing treatments and next-generation adeno-associated virus capsids, reported fourth quarter and full year 2021 financial and operating results.

MiroBio, a biotechnology company advancing checkpoint agonist therapies to restore immune balance, announced two key additions to its leadership team.

Entera Bio Ltd., a leader in the development of orally delivered large molecule therapeutics, announced financial and operating results for the year ended December 31, 2021, and provided an update on its clinical and pre-clinical programs.

Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the fourth quarter and year ended December 31, 2021.